Post-partum hemorrhage in women with rare bleeding disorders

Flora Peyvandi, Marzia Menegatti, Simona Maria Siboni

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Post-partum hemorrhage (PPH) accounts for a substantial fraction of maternal deaths in the general population. Among all women, however, those affected with rare bleeding disorders (RBDs) represent a particular group since to usual bleeding symptoms, they are likely to experience bleedings associated to obstetrical and gynaecological problems. Pregnancy and childbirth, two important stages in the life of a woman, pose a special clinical challenge in women with RBDs, since information about these issues are really scarce and limited to few case reports. These data show that all women with RBDs, except for FXI deficiency, have to be considered potentially at risk for developing PPH, therefore they should be monitored carefully during and immediately after pregnancy. The implication is that women with bleeding disorders may require prophylaxis and/or close observation for several weeks and should be followed by a multidisciplinary team including expertises such as laboratory haematologist, obstetrician-gynaecologist, anaesthesiologist, family physician, and laboratory technician.

Original languageEnglish
JournalThrombosis Research
Volume127
Issue numberSUPPL. 3
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Hemorrhage
Laboratory Personnel
Pregnancy
Maternal Death
Family Physicians
Observation
Parturition
Population

Keywords

  • Close observation
  • Multidisciplinary team
  • Post-partum hemorrhage (PPH)
  • Prophylaxis
  • Rare bleeding disorders (RBDs)

ASJC Scopus subject areas

  • Hematology

Cite this

Post-partum hemorrhage in women with rare bleeding disorders. / Peyvandi, Flora; Menegatti, Marzia; Siboni, Simona Maria.

In: Thrombosis Research, Vol. 127, No. SUPPL. 3, 02.2011.

Research output: Contribution to journalArticle

@article{2d97a540b79348bdba1afef994724ab5,
title = "Post-partum hemorrhage in women with rare bleeding disorders",
abstract = "Post-partum hemorrhage (PPH) accounts for a substantial fraction of maternal deaths in the general population. Among all women, however, those affected with rare bleeding disorders (RBDs) represent a particular group since to usual bleeding symptoms, they are likely to experience bleedings associated to obstetrical and gynaecological problems. Pregnancy and childbirth, two important stages in the life of a woman, pose a special clinical challenge in women with RBDs, since information about these issues are really scarce and limited to few case reports. These data show that all women with RBDs, except for FXI deficiency, have to be considered potentially at risk for developing PPH, therefore they should be monitored carefully during and immediately after pregnancy. The implication is that women with bleeding disorders may require prophylaxis and/or close observation for several weeks and should be followed by a multidisciplinary team including expertises such as laboratory haematologist, obstetrician-gynaecologist, anaesthesiologist, family physician, and laboratory technician.",
keywords = "Close observation, Multidisciplinary team, Post-partum hemorrhage (PPH), Prophylaxis, Rare bleeding disorders (RBDs)",
author = "Flora Peyvandi and Marzia Menegatti and Siboni, {Simona Maria}",
year = "2011",
month = "2",
doi = "10.1016/S0049-3848(11)70031-7",
language = "English",
volume = "127",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Post-partum hemorrhage in women with rare bleeding disorders

AU - Peyvandi, Flora

AU - Menegatti, Marzia

AU - Siboni, Simona Maria

PY - 2011/2

Y1 - 2011/2

N2 - Post-partum hemorrhage (PPH) accounts for a substantial fraction of maternal deaths in the general population. Among all women, however, those affected with rare bleeding disorders (RBDs) represent a particular group since to usual bleeding symptoms, they are likely to experience bleedings associated to obstetrical and gynaecological problems. Pregnancy and childbirth, two important stages in the life of a woman, pose a special clinical challenge in women with RBDs, since information about these issues are really scarce and limited to few case reports. These data show that all women with RBDs, except for FXI deficiency, have to be considered potentially at risk for developing PPH, therefore they should be monitored carefully during and immediately after pregnancy. The implication is that women with bleeding disorders may require prophylaxis and/or close observation for several weeks and should be followed by a multidisciplinary team including expertises such as laboratory haematologist, obstetrician-gynaecologist, anaesthesiologist, family physician, and laboratory technician.

AB - Post-partum hemorrhage (PPH) accounts for a substantial fraction of maternal deaths in the general population. Among all women, however, those affected with rare bleeding disorders (RBDs) represent a particular group since to usual bleeding symptoms, they are likely to experience bleedings associated to obstetrical and gynaecological problems. Pregnancy and childbirth, two important stages in the life of a woman, pose a special clinical challenge in women with RBDs, since information about these issues are really scarce and limited to few case reports. These data show that all women with RBDs, except for FXI deficiency, have to be considered potentially at risk for developing PPH, therefore they should be monitored carefully during and immediately after pregnancy. The implication is that women with bleeding disorders may require prophylaxis and/or close observation for several weeks and should be followed by a multidisciplinary team including expertises such as laboratory haematologist, obstetrician-gynaecologist, anaesthesiologist, family physician, and laboratory technician.

KW - Close observation

KW - Multidisciplinary team

KW - Post-partum hemorrhage (PPH)

KW - Prophylaxis

KW - Rare bleeding disorders (RBDs)

UR - http://www.scopus.com/inward/record.url?scp=79251477186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251477186&partnerID=8YFLogxK

U2 - 10.1016/S0049-3848(11)70031-7

DO - 10.1016/S0049-3848(11)70031-7

M3 - Article

C2 - 21262429

AN - SCOPUS:79251477186

VL - 127

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - SUPPL. 3

ER -